| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/26/2002 | CN1355297A Polypeptide-human ubiquitin activating enzyme E1-13.53 and polynucleotide for coding it |
| 06/26/2002 | CN1355296A Polypeptide-human leucoma pro protein conveyzyme 10.89 and polynucleotide for coding it |
| 06/26/2002 | CN1355252A Hetergeneous product of bio-active protein and its preparing process |
| 06/26/2002 | CN1355199A Polypeptide-human macroprotein 0767-19.36 and polynucleotide for coding it |
| 06/26/2002 | CN1355049A Analgesic and its preparing process |
| 06/26/2002 | CN1086584C Medicine for preventing chronic lead poisoning |
| 06/25/2002 | USRE37766 K. lactis pyruvate-decarboxylase promoter and use thereof |
| 06/25/2002 | US6410775 APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
| 06/25/2002 | US6410720 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/25/2002 | US6410712 Nucleotide sequences coding preferential polypeptide for use in treatment of sleep disorder |
| 06/25/2002 | US6410711 Nucleotide sequences coding preferential polypeptide for use in human therapeutics and diagnostics |
| 06/25/2002 | US6410710 Nucleotides sequences coding protein for use in treatment of autoimmune response defects |
| 06/25/2002 | US6410709 Polypeptide; for use in diagnosis and treatment of inflammatory and cell proliferative disorders |
| 06/25/2002 | US6410708 Nucleotide sequences coding preferential protein for use in the diagnosis and treatment of inflammation, cancer and inflammatory bowel disease |
| 06/25/2002 | US6410704 Nucleotide sequences coding enzymatic polypeptide for use in treatment of viral disease |
| 06/25/2002 | US6410701 Human neuropeptide receptor |
| 06/25/2002 | US6410697 Isolating mammalian glycoprotein; obtain sample with glycoprotein, incubate with antibody, apply solution to matrix, elute and recover mammalian glycoprotein |
| 06/25/2002 | US6410696 Cyclosporin immunoassay |
| 06/25/2002 | US6410693 Inhibitors of the JNK signal transduction pathway and methods of use |
| 06/25/2002 | US6410691 Monoclonal antibody for use in diagnosis and treatment of immunlogical defects, cancer and rheumatic diseases |
| 06/25/2002 | US6410690 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 06/25/2002 | US6410688 Def1 |
| 06/25/2002 | US6410686 Galanin receptor 2 protein |
| 06/25/2002 | US6410685 Reducing stress in mammals; obtain mammal, administer tripeptide, monitor mammal for reduction in products of stress response |
| 06/25/2002 | US6410684 Serine protease inhibitors |
| 06/25/2002 | US6410645 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
| 06/25/2002 | US6410598 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
| 06/25/2002 | US6410585 Therapy for non-insulin depend diabetes |
| 06/25/2002 | US6410576 Antiinflammatory agents; cardiovascular disorders |
| 06/25/2002 | US6410575 Administering (5-aryl-1,2,4-thiadiazol)-3-yl thiourea and urea derivatives to treat hepatitis, hiv and kaposi sarcoma, as viricides and anticarcinogenic agents |
| 06/25/2002 | US6410548 Spiropiperidine derivatives as melanocortin receptor agonists |
| 06/25/2002 | US6410531 For therapy of hepatitis c virus (hcv) infection |
| 06/25/2002 | US6410524 Concurrent administering |
| 06/25/2002 | US6410518 Antisense oligonucleotide inhibition of raf gene expression |
| 06/25/2002 | US6410515 Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| 06/25/2002 | US6410514 Tissue specific prodrug |
| 06/25/2002 | US6410513 Polypeptides |
| 06/25/2002 | US6410512 Inhibitors of proteasomal activity for stimulating hair growth |
| 06/25/2002 | US6410511 Formulations for amylin agonist peptides |
| 06/25/2002 | US6410510 Administration modified ciliary neurotrophic factors |
| 06/25/2002 | US6410509 Antigen; induce immunology response |
| 06/25/2002 | US6410508 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 06/25/2002 | US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/25/2002 | US6410506 Transforming growth factor α HII |
| 06/25/2002 | US6410335 Circulating insulin-like growth factor-I and prostate cancer risk |
| 06/25/2002 | US6410328 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 06/25/2002 | US6410326 Destroying human tumor cells; obtain tumor cells, transform with replication defective vector, incubate with prodrug, monitor destruction of cells |
| 06/25/2002 | US6410325 Antisense modulation of phospholipase A2, group VI (Ca2+-independent) expression |
| 06/25/2002 | US6410324 Nucleotide sequences for use in the treatment of hyperlipidemia, atherosclerosis, hypercholesterolemia, narcolepsy and autoimmune disease |
| 06/25/2002 | US6410323 Nucleotide sequences for use in the treatment of cell proliferation defects |
| 06/25/2002 | US6410322 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 06/25/2002 | US6410320 Kidney stem cells; for use in treatment of kidney defects |
| 06/25/2002 | US6410318 Antibodies directed against binding-associated epitopes |
| 06/25/2002 | US6410296 Herpes virus proteinase and method of assaying |
| 06/25/2002 | US6410288 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
| 06/25/2002 | US6410286 Asparaginyl tRNA synthetase from Staphylococcus Aureus |
| 06/25/2002 | US6410272 Production of thrombin inhibitors |
| 06/25/2002 | US6410269 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 06/25/2002 | US6410267 Human GTPase-associated proteins |
| 06/25/2002 | US6410263 Histidine kinase |
| 06/25/2002 | US6410250 Sustained delivery device and methods of making and using the same |
| 06/25/2002 | US6410249 Odorant receptors |
| 06/25/2002 | US6410240 Complexing |
| 06/25/2002 | US6410238 Hybrid nucleic acids; cancer diagnosis |
| 06/25/2002 | US6410232 Molecules of the follistatin-related protein family and uses thereof |
| 06/25/2002 | US6410224 Cleavage of protein using enzyme; therapy for inflammation, asthma, rheumatic diseases, autoimmune diseases |
| 06/25/2002 | US6410058 Methods of use for dietary compositions comprising lactoferrin and colostrum |
| 06/25/2002 | US6410044 Crosslinkable macromers |
| 06/25/2002 | US6410030 Polypeptide used as immunogenic element carried by peptide sequence between amino acid residues 130 and 230 of sequence of g protein of human respiratory syncytial virus of subgroups a and b, or of bovine respiratory syncytial virus |
| 06/25/2002 | US6410029 2-methoxyestradiol-induced apoptosis in cancer cells |
| 06/25/2002 | US6410028 Administering complex of heat shock protein noncovalently bound to antigenic peptide or protein to elicit immune response, wherein complex is made in vitro, and antigenic peptide or protein is not isolated from complex |
| 06/25/2002 | US6410022 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 06/25/2002 | US6410020 Monoclonal antibody reactive to human CETP and assay method for human CETP |
| 06/25/2002 | US6410019 Topical administration of immunoglobulins brings about remission of inflammatory process without causing any toxic or unwanted side effects |
| 06/25/2002 | US6410018 Composition and method for lactose hydrolysis |
| 06/25/2002 | US6410015 Selecting from bone marrow-derived cells population responsive to transforming growth factor beta-1, using as vehicles for transferring genes encoding therapeutic protein to mammal |
| 06/25/2002 | US6410014 Administering protein-tyrosine kinase chimeras capable of directing cytotoxic t lymphocytes to specifically recognize and lyse target cells |
| 06/25/2002 | US6410011 Treatment of restenosis by gene therapy, comprising the administration of a recombinant adenovirus containing a suicide gene |
| 06/25/2002 | US6410010 Recombinant P53 adenovirus compositions |
| 06/25/2002 | US6410009 Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
| 06/25/2002 | US6410008 Chimeric IL-10 proteins and uses thereof |
| 06/25/2002 | US6410007 Erectile dysfunction, vasodilation |
| 06/25/2002 | US6409716 Drug delivery |
| 06/25/2002 | US6408854 Insulin delivery enhanced by coached breathing |
| 06/25/2002 | CA2245462C Methods of modulating cell proliferation through telomerase modulation |
| 06/25/2002 | CA2201587C Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 06/25/2002 | CA2140281C Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 06/25/2002 | CA2135648C Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 06/25/2002 | CA2095300C Use of genetically modified cells to treat defects, disease or damage of the central nervous system |
| 06/25/2002 | CA2094347C A method of producing a factor viii preparation |
| 06/25/2002 | CA2081659C Recombinant human factor viii derivatives |
| 06/25/2002 | CA2045546C Treatment of pulmonary dysfunction and ventilator dependency with growth hormone |
| 06/25/2002 | CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/25/2002 | CA2017379C Purification and characterization of a glioma-derived growth factor |
| 06/23/2002 | WO2002040654A2 A human serpin secreted from lymphoid cells lsi-01 |
| 06/23/2002 | CA2429179A1 Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01 |
| 06/21/2002 | CA2365818A1 Personal care compositions |
| 06/21/2002 | CA2364841A1 A disinfectant for teats of animals, and a method for improving microorganism-environment harmful for animals |
| 06/20/2002 | WO2002048715A2 Inflammatory markers for detection and prevention of diabetes mellitus |
| 06/20/2002 | WO2002048708A2 Assay for anti-viral agent |